Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-02-02 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
220202 - Transparantieverklaring persbericht FMR LLC .pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) from UCB NV, announcing that FMR LLC has notified them of a change in their shareholding, specifically crossing below the 5% threshold on January 27, 2022. This type of filing, which reports changes in significant share ownership by an entity or individual, directly corresponds to the definition of a Major Shareholding Notification (MRQ). The content details the previous and current number of voting rights held by various related entities under the FMR LLC umbrella, confirming it is a notification of a change in significant shareholding.
2022-02-02 Dutch
PDF - ENG - 28.01.22.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Disposals of own shares' and details transactions where the company disposed of its own shares (1,300 and 250 shares) related to the exercise of stock options under an LTI Plan. This activity directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. The document is short and appears to be a formal regulatory announcement ('regulated information').
2022-01-28 English
PDF - FR - 28.01.22.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and explicitly states that UCB SA is making a public disclosure following the exercise of options by personnel, resulting in the sale of UCB shares OTC. The content details the quantity of shares alienated and the transaction dates. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a direct report of the transaction, not an announcement of a report's publication.
2022-01-28 French
PDF- NL - 28.1.22.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Vervreemding van eigen aandelen' (Disposal of own shares) and details transactions where UCB shares were delivered to employees as part of long-term incentive plans (stock options). This directly relates to the company buying back or issuing its own shares, specifically in the context of employee share schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive transaction details.
2022-01-28 Dutch
PA - ENG - 21.01.22.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Disposals of own shares' and details the transaction of UCB shares OTC related to the exercise of stock options under Long Term Incentive Programs. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation plans. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal announcement (regulated information) detailing these specific transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core data itself.
2022-01-21 English
PA - FR - 21.01.22.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and explicitly states that UCB SA is making a public disclosure following the exercise of options by personnel, resulting in the alienation (sale/transfer) of UCB shares OTC. This transaction type, where a company deals in its own shares, directly corresponds to the definition of 'Transaction in Own Shares'. The filing is dated January 21, 2022, and details specific transactions from January 19, 2022. The French term 'Aliénation d'actions propres' is a direct equivalent to share repurchase or treasury stock transaction reporting, fitting the 'POS' category.
2022-01-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.